MedPath

Preventing the Spread of Infection in Nursing Homes

Not Applicable
Completed
Conditions
Staphylococcus Aureus
Interventions
Other: Targeted gown and glove use
Registration Number
NCT03319368
Lead Sponsor
University of Maryland, Baltimore
Brief Summary

This study evaluates the feasibility of targeting more frequent gown and glove use for specific high risk moments of care in specific nursing home residents in order to prevent Staphylococcus aureus (SA) acquisition and infection.

Detailed Description

Nursing homes are settings with a high rate of Staphylococcus aureus (SA) acquisition, which leads to infection, particularly for short stay residents. The current standard of care for preventing SA acquisition and SA infection in nursing homes is Standard Precautions (gowns and gloves for anticipated contact with blood, body fluids, skin breakdown or mucous membranes) for all residents.

The investigators propose a feasibility study of a novel strategy, the addition of targeted gown and glove use, to prevent SA acquisition and SA infection in residents of nursing homes. Rather than wearing gowns and gloves for all care activities to prevent transmission, gown and glove use can be targeted to specific high risk "moments" of care for specific high risk residents. High risk "moments" for gown and glove use are care activities most likely to transmit SA based on prior research. Residents with chronic wounds and medical devices are: 1) most likely to be colonized with SA; 2) most likely to acquire SA; 3) most likely to transmit SA to healthcare worker clothing and hands; and 4) most likely to develop a SA infection based on prior research and thus would be considered high risk residents.

The investigators will perform a quasi-experimental (before-after) study of this intervention, targeted gown and glove use, at two community-based nursing homes to demonstrate its feasibility and evaluate its effect on SA acquisition and SA infection rates.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
367
Inclusion Criteria
  • Age ≥18 years
  • Reside in a participating nursing home
Read More
Exclusion Criteria
  • Identified by nursing home staff as combative or with other behavioral problems which could lead to agitation if approached by project staff
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Intervention: Targeted gown and glove useTargeted gown and glove useAdditional gowns and gloves used for high risk care activities
Primary Outcome Measures
NameTimeMethod
Rates of Staphylococcus Aureus Acquisition: Percentage of Short Stay Participants Who Acquired MRSA or MSSA (or Both) During the Study Period5 months: 2 months in the baseline period, one month to prep the intervention, then 2 months in the intervention period

Rates of Staphylococcus aureus acquisition in the baseline and intervention periods: Participants were swabbed in the anterior nares and inguinal fold at nursing home admission (or start of study period) and again at discharge (or end of study period). This is the percentage of participants who acquired MRSA or MSSA (or both) during the study period.

Secondary Outcome Measures
NameTimeMethod
Rates of Staphylococcus Aureus Transmission: Percentage of Short Stay Participants Who Acquired MRSA or MSSA (or Both) From MRSA/MSSA Transmission From Another Study Participant During the Study Period5 months

Rates of Staphylococcus aureus transmission in the baseline and intervention periods: Participants were swabbed in the anterior nares and inguinal fold at nursing home admission (or start of study period) and again at discharge (or end of study period). The DNA sequences of each SA isolate from each acquisition were evaluated to see if there was a match to another epidemiologically linked (same floor, same study period) SA isolate. This is the percentage of participants who acquired MRSA or MSSA (or both) from MRSA/MSSA transmission from another study participant during the study period.

Trial Locations

Locations (2)

Lorien Riverside

🇺🇸

Belcamp, Maryland, United States

Lorien Mays Chapel

🇺🇸

Lutherville-Timonium, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath